News & Articles

May 20, 2019

Northway Biotechpharma is Changing its Management Structure and Appoints Giedrius ┼Żunda as Chief Executive Officer

Biotechpharma UAB, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, is pleased to announce the appointment of Giedrius ┼Żunda as Chief Executive Officer effective from 3 December 2018.

May 20, 2019

Northway Biotechpharma to Expand Process Development and GMP Manufacturing Capacity to 5,000 L

Northway Biotechpharma will expand its existing manufacturing facility by adding a new line of bioreactors

March 08, 2019

Speed and Customized Support from Gene to GMP Manufacturing

Emerging, small and mid-sized biopharma companies with limited resources need contract development and manufacturing partners that can offer personalized support. By combining a range of integrated services supporting biologics throughout the life cycle, with the benefits of an expert, young and dynamic workforce, Biotechpharma UAB is uniquely positioned to support biopharma companies across the globe.

May 21, 2019

State-of-the-art Biologics Manufacturing in an Unexpected Location

Lithuania is a small country in the Baltic region of northeastern Europe bordering the southeastern shore of the Baltic Sea. While largely a service economy, Lithuania, which is a member of the European Union, has a substantial industrial sector that produces chemical products, plastics, machinery and appliances. Biotechpharma UAB, a rapidly growing contract development and manufacturing organization located in Vilnius, is adding biologic drug substances and drug products to the list of goods exported throughout Europe, North America, Asia and the Middle East.